Advertisement
U.S. markets open in 9 hours 10 minutes

ChromaDex Corporation (CDXC)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
2.9900+0.5900 (+24.58%)
At close: 04:00PM EDT
3.0000 +0.01 (+0.33%)
After hours: 07:59PM EDT

ChromaDex Corporation

10900 Wilshire Blvd
Suite 600
Los Angeles, CA 90024
United States
310 388 6706
https://www.chromadex.com

Sector(s)Healthcare
IndustryBiotechnology
Full Time Employees106

Key Executives

NameTitlePayExercisedYear Born
Mr. Frank Louis Jaksch Jr.Co-Founder & Chairman292.27kN/A1968
Mr. Robert N. FriedCEO & Director735.54kN/A1960
Ms. Brianna GerberChief Financial Officer509.82kN/A1981
Dr. Andrew Shao Ph.D.Senior Vice President of Global Regulatory & Scientific AffairsN/AN/AN/A
Heather Van BlarcomSenior VP of Legal & Corporate SecretaryN/AN/AN/A
Alex WorshamVice President of Global Marketing & CommunicationsN/AN/AN/A
Mr. David KroesSenior Vice President of People MattersN/AN/AN/A
Ms. Chu YanManaging Director of Asia PacificN/AN/AN/A
Mr. Jason CampbellSenior Vice President of Business DevelopmentN/AN/AN/A
Kendall KnyschHead of Media Relations & PartnershipsN/AN/AN/A
Amounts are as of December 31, 2022 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

ChromaDex Corporation operates as a bioscience company focusing on developing healthy aging products. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingredients directly to consumers and distributors; and develops and commercializes proprietary-based ingredient technologies and supplies these ingredients as raw materials to the manufacturers of consumer products. The company also commercializes NAD+ precursor nicotinamide riboside as the flagship ingredient NIAGEN; NIAGEN as an active ingredient in its consumer products under the TRU NIAGEN name; and Immulina, a spirulina extract with predominant active compounds of Braun-type lipoproteins for supporting human immune function. In addition, it offers phytochemical reference standards, and other research and development services. The company distributes TRU NIAGEN products direct to consumers through its propriety e-commerce platform TRUNIAGEN.com, Amazon, ShopHQ, and other internet marketplaces, as well as specialty retailers and direct healthcare practitioners in the United States. ChromaDex Corporation was founded in 1999 and is headquartered in Los Angeles, California.

Corporate Governance

ChromaDex Corporation’s ISS Governance QualityScore as of March 1, 2024 is 5. The pillar scores are Audit: 8; Board: 6; Shareholder Rights: 2; Compensation: 6.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.